An international team of scientists has shed new light on how a mutation in a protein causes acute myeloid leukaemia (AML), a type of blood cancer. The findings have implications for our understanding of AML, and the way leukaemias are treated. The work, which is partly funded by the EU, is published in the latest edition of the journal Cancer Cell.
Who Voted for this Story
Comments